Classer les publications sur l'année

  • Santé Publique et Epidémiologie

    Fuel poverty in France: Adapting an English Methodology to assess the health cost implications

    EZRATTY V, ORMANDY D, LAURENT MH, DUBURCQ A, LENCHI C, BOUTIERE F, CABANES PA, LAMBROZO J

    2017 - Indoor and Built Environment ; 26(7): 999-1008

  • Santé Publique et Epidémiologie

    Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes

    MOUTAIROU A, ROUSSEL R, CHARBONNEL  B,  LEYE A,  DETOURNAY B,  MOHAMMEDI K,  POTIER L

    2017 - Diabetes Metab ; 43 (4) : 392-394

  • Santé Publique et Epidémiologie

    Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases

    BAUJAT G, CHOQUET R, BOUEE S, JEANBAT V, COUROUVE C, RUEL A, MICHOT C, LE QUAN SANG KH, LAPIDUS D, MESSIAEN C, LANDAIS P, CORMIER-DAIRE V

    2017 - Orphanet Journal of Rare Diseases ; (12): 123

  • Pharmaco-Epidémiologie

    The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study

    BALKAU B, CHARBONNEL B, PENFORNIS P, CHRAIBI N, LAHOUEGUE A, FAURE C, THOMAS-DELECOURT F, DETOURNAY B

    2017 - Diabetes Ther ; 8 ; 1147-1162

  • Pharmaco-Epidémiologie

    Pratique de l’autosurveillance glycémique en France: données d’une enquête nationale

    GUERCI B, BENHAMOU PY, DURAIN D, BAHLOUL A, JEANBAT V, DETOURNAY B

    2017 - Med Mal Metab ; 11-5 : 458-467

  • Pharmaco-Epidémiologie

    Survey of clinical practice patterns in the management of 992 hyperthyroid patients in France

    GOICHOT B, BOUEE S, CASTELLO-BRIDOUX C, CARON P

    2017 - Eur Thyroid J ; 6 : 152-159

  • Biométrie et Analyses de bases de données

    Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database

    TILLEUL P,  JACOT W,  EMERY C, LAFUMA  A,  GOURMELEN J

    2017 - J Med Economics ; 20(12):1261-1267

  • Économie de la santé

    Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era

    CACOUB P, VAUTIER M, DESBOIS AC, LAFUMA A, SAADOUN D

    2017 - Liver International ; 37(12):1805-1813

  • Biométrie et Analyses de bases de données

    Excess mortality between 2007 and 2014 among patients with Clostridium difficile infection: a French health insurance database analysis

    BARBUT F, BOUEE S, LONGEPIERRE L, GOLDBERG M, BENSOUSSAN C, LEVY-BACHELOT L

    2017 - J Hosp Infect ; 98(1):21-28

  • Pharmaco-Epidémiologie

    Impact of rheumatoid arthritis on career progression, productivity, and employability: The PRET Study

    BERTIN P, FAGNANI F, DUBURCQ A, WORONOFF AS, CHAUVIN P, CUKIERMAN G, TROPÉ-CHIROL S, JOUBERT JM, KOBELT G

    2016 - Joint Bone Spine ; 83 - 1 : 47-52

  • Pharmaco-Epidémiologie

    Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.

    BOUEE S, EMERY C, SAMSON A, GOURMELEN J, BAILLY C, COTTE FE.

    2016 - Thromb J. ; 14 (4) : doi: 10.1186

  • Pharmaco-Epidémiologie

    Prevalence of Gout in the Adult Population of France.

    BARDIN T, BOUEE S, CLERSON P, CHALES G, FLIPO RM, LIOTE F, PEREZ V, POIRAUD T, SCHAEVERBEKE T, RICHETTE P.

    2016 - Arthritis Care Res ; 68 (2) : 261-6

  • Pharmaco-Epidémiologie

    Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.

    FAGNANI F, PHAM T, CLAUDEPIERRE P, BERENBAUM F, DE CHALUS T, SAADOUN C, JOUBERT JM, FAUTREL B.

    2016 - J Med Econ ; 25 : 1-10

  • Santé Publique et Epidémiologie

    Bouge ta santé à Clichy-sous-Bois » : une approche intersectorielle de l’activité physique

    CZAPLICKI G, DONIO V, NOSSEREAU C, FIKOJEVIC M, RICHARD D

    2016 - Santé publique ; 28 (supp.1) : 175-8

  • Économie de la santé

    Low rate of intensification in type 2 diabetic patients inadequately controlled with basal insulin: the INTERDIA study

    ROUSSEL R, GOURDY P, GAUTIER JF, GUERCI B, RACCAH D, BEHAR M, ROBERT J,DETOURNAY B

    2016 - Diabetes Manag ; 6-6 : 119–127